title: Determinants of the establishment of human immunodeficiency virus type 1 latency.
abstract: Recent research has emphasized the notion that human immunodeficiency virus type 1 (HIV-1) latency is controlled by a restrictive histone code at, or DNA methylation of, the integrated viral promoter (long terminal repeat [LTR]). The present concept of HIV-1 latency has essentially been patterned from the principles of cellular gene regulation. Here we introduce an experimental system that allows for the qualitative and quantitative kinetic study of latency establishment and maintenance at the population level. In this system, we find no evidence that HIV-1 latency establishment is the consequence of downregulation of initial active infection followed by the establishment of a restrictive histone code at the viral LTR. Latent infection was established following integration of the virus in the absence of viral gene expression (silent integration) and was a function of the NF-kappaB activation level in the host cell at the time of infection. In the absence of a role for epigenetic regulation, we demonstrate that transcriptional interference, a mechanism that has recently been suggested to add to the stabilization of HIV-1 latency, is the primary mechanism to govern latency maintenance. These findings provide direct experimental evidence that the high number of viral integration events (>90%) found in actively expressed genes of CD4(+) memory T cells from highly active antiretroviral therapy-suppressed patients represent indeed latent infection events and that transcriptional interference may be the primary mechanism to control HIV-1 latency in vivo. HIV-1 latency may thus not be governed by the principles of cellular gene regulation, and therapeutic strategies to deplete the pool of latently HIV-1-infected cells should be reconsidered.
authors.affiliation: Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA. okutsch@uab.edu.
authors.forename: Alexandra
authors.initials: A
authors.lastname: Duverger
authors.forename: Jennifer
authors.initials: J
authors.lastname: Jones
authors.forename: Jori
authors.initials: J
authors.lastname: May
authors.forename: Frederic
authors.initials: F
authors.lastname: Bibollet-Ruche
authors.forename: Frederic A
authors.initials: FA
authors.lastname: Wagner
authors.forename: Randall Q
authors.initials: RQ
authors.lastname: Cron
authors.forename: Olaf
authors.initials: O
authors.lastname: Kutsch
mesh_terms: D002460:Cell Line; D015497:HIV-1 / Q000502:physiology*; D006801:Humans; D016328:NF-kappa B / Q000378:metabolism; D014158:Transcription, Genetic; D016662:Virus Integration; D017735:Virus Latency
chemical_list: D016328:NF-kappa B